SHOC2 and COVID-19: The mean (SD) number of days since the onset of initial COVID-19 symptoms in patients enrolled in Part A were 7.2 (2.58) days for the SOC1 group and 6.6 (2.26) days for the 2-DG 63 mg group, and for those enrolled in Part B were 4.5 (1.41) days, 4.3 (1.46) days, and 4.4 (1.40) days for the 2-DG 90 mg, 2-DG 126 mg, and SOC2 groups, respectively (Table 1).